Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New York
- 16 August 1984
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 311 (7) , 467-468
- https://doi.org/10.1056/nejm198408163110712
Abstract
To the Editor: Of the 4861 cases of the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control (CDC) through June 18, 1984, 852 (18 per cent) occurred in persons in whom intravenous-drug use was the only known risk factor. The great majority of such cases (82 per cent) have occurred in the New York-New Jersey area.1 Lymphadcnopathy-associatcd virus2 and human T-ccll lymphotropic virus III3 are human retroviruses recently associated with AIDS. This letter reports the seroprevalence of antibody to lymphadenopathy-associatcd virus among New York City drug-detoxification patients without diagnosed AIDS.Scrum specimens were collected from 86 intravenous-drug . . .Keywords
This publication has 3 references indexed in Scilit:
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Acquired immune deficiency syndrome (AIDS) trends in the United States, 1978–1982The American Journal of Medicine, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983